Peter T
Senior Member (Voting Rights)
I agree with @Trish. Under current definitions, research without participants displaying PEM is not research into ME/CFS.
That research into ME/CFS requires ME/CFS participants to display PEM is surely self evident. There may be reasons to compare people with ME/CFS with others displaying overlapping symptoms but not experiencing PEM, but that is a completely separate question to that addressed by this thread.
There is also the issue implicit in the header for this thread that though research into ME/CFS will require participants experience PEM, the target of that research may or may not relate to PEM, that depends on the research question.
I think it is worth while giving thought to people who drop by the wayside as definitions of ME/CFS are refined, and if we develop clinically useful diagnostic testing or biomarkers yet more people may drop by the wayside. However that does not justify watering down patient selection criteria for research purposes. Clinical criteria for planning symptom management needs also to take into account PEM, but there may be significant overlap in management for those displaying overlapping symptoms without PEM. So there may be some research questions that don’t necessarily require PEM, but surely that needs to be made explicit and it would make sense to know which participants did or did not have PEM if we are not to repeat previous mistakes in generalising inappropriately between different clinical groupings.
That research into ME/CFS requires ME/CFS participants to display PEM is surely self evident. There may be reasons to compare people with ME/CFS with others displaying overlapping symptoms but not experiencing PEM, but that is a completely separate question to that addressed by this thread.
There is also the issue implicit in the header for this thread that though research into ME/CFS will require participants experience PEM, the target of that research may or may not relate to PEM, that depends on the research question.
I think it is worth while giving thought to people who drop by the wayside as definitions of ME/CFS are refined, and if we develop clinically useful diagnostic testing or biomarkers yet more people may drop by the wayside. However that does not justify watering down patient selection criteria for research purposes. Clinical criteria for planning symptom management needs also to take into account PEM, but there may be significant overlap in management for those displaying overlapping symptoms without PEM. So there may be some research questions that don’t necessarily require PEM, but surely that needs to be made explicit and it would make sense to know which participants did or did not have PEM if we are not to repeat previous mistakes in generalising inappropriately between different clinical groupings.